In September, we received a positive opinion from the Bioethics Committee of the District Medical Chamber in Warsaw regarding our medical device, the OrthoNail hybrid intramedullary nail.
The resolution, dated September 29 of this year, concerns the outcome of a clinical trial entitled “A multicenter, open-label clinical trial to evaluate the safety and effectiveness of the OrthoNail hybrid intramedullary nail compared to the PRECICE® intramedullary nail in the treatment of adult patients with unequal lower limb length or in femoral lengthening in cosmetic surgery.”
Thus, we were able to prove once again the unquestionable progress we are bringing to the lower limb asymmetry rehabilitation market with our product.
